blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1684742

EP1684742 - USE OF 1-OXADIBENZO [E,H] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS [Right-click to bookmark this link]
Former [2006/31]USE OF 1-OXADIBENZO E,H AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
[2008/51]
StatusNo opposition filed within time limit
Status updated on  20.11.2009
Database last updated on 07.10.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
Prilaz Baruna Filipovica 29
10000 Zagreb / HR
[2009/03]
Former [2006/37]For all designated states
GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
Prilaz Baruna Filipovica 29
10000 Zagreb / HR
Former [2006/31]For all designated states
PLIVA-ISTRAZIVACKI INSTITUT d.o.o.
Prilaz baruna Filipovica 29
10000 Zagreb / HR
Inventor(s)01 / MERCEP, Mladen
Majstora Radonje 10
10000 Zagreb / HR
02 / MESIC, Milan
Slavenskog 8
10000 Zagreb / HR
03 / PESIC, Dijana
Prokljanska 18
22000 Sibenik / HR
 [2006/31]
Representative(s)von Füner, Nicolai, et al
v. Füner Ebbinghaus Finck Hano Patentanwälte Mariahilfplatz 2&3
81541 München / DE
[2006/31]
Application number, filing date04798731.819.11.2004
[2006/31]
WO2004HR00052
Priority number, dateHR2003000095521.11.2003         Original published format: HR 20030955
[2006/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005049010
Date:02.06.2005
Language:EN
[2005/22]
Type: A1 Application with search report 
No.:EP1684742
Date:02.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application.
[2006/31]
Type: B1 Patent specification 
No.:EP1684742
Date:14.01.2009
Language:EN
[2009/03]
Search report(s)International search report - published on:EP02.06.2005
ClassificationIPC:A61K31/343, A61K31/34, A61K31/38, A61K31/55, A61P25/00
[2006/31]
CPC:
A61K31/34 (EP,US); A61K31/343 (EP,US); A61K31/38 (EP,US);
A61K31/55 (EP,US); A61P15/08 (EP); A61P25/00 (EP);
A61P25/06 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P3/04 (EP); A61P35/00 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/31]
Extension statesAL31.05.2006
HR31.05.2006
LT31.05.2006
LV31.05.2006
MK31.05.2006
YU31.05.2006
TitleGerman:VERWENDUNG VON 1-OXADIBENZO [E,H] AZULENEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN FORMULIERUNGEN FÜR DIE BEHANDLUNG UND PRÄVENTION VON ERKRANKUNGEN UND STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS[2008/51]
English:USE OF 1-OXADIBENZO [E,H] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS[2008/51]
French:UTILISATION DE 1-OXADIBENZO [E, H] AZULENES POUR LA FABRICATION DE PREPARATIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT ET A LA PREVENTION DE MALADIES ET DE TROUBLES DU SYSTEME NERVEUX CENTRAL[2008/51]
Former [2006/31]VERWENDUNG VON 1-OXADIBENZO E,H AZULENEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN FORMULIERUNGEN FÜR DIE BEHANDLUNG UND PRÄVENTION VON ERKRANKUNGEN UND STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS
Former [2006/31]USE OF 1-OXADIBENZO E,H AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
Former [2006/31]UTILISATION DE 1-OXADIBENZO E, H AZULENES POUR LA FABRICATION DE PREPARATIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT ET A LA PREVENTION DE MALADIES ET DE TROUBLES DU SYSTEME NERVEUX CENTRAL
Entry into regional phase31.05.2006National basic fee paid 
31.05.2006Designation fee(s) paid 
31.05.2006Examination fee paid 
Examination procedure31.05.2006Examination requested  [2006/31]
29.09.2006Despatch of a communication from the examining division (Time limit: M06)
22.03.2007Reply to a communication from the examining division
13.06.2008Communication of intention to grant the patent
09.10.2008Fee for grant paid
09.10.2008Fee for publishing/printing paid
Opposition(s)15.10.2009No opposition filed within time limit [2009/52]
Fees paidRenewal fee
31.05.2006Renewal fee patent year 03
06.11.2007Renewal fee patent year 04
07.11.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.01.2009
CY14.01.2009
CZ14.01.2009
DK14.01.2009
EE14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
RO14.01.2009
SI14.01.2009
SK14.01.2009
TR14.01.2009
BG14.04.2009
SE14.04.2009
GR15.04.2009
IS14.05.2009
PT15.06.2009
HU15.07.2009
[2011/44]
Former [2011/32]AT14.01.2009
CZ14.01.2009
DK14.01.2009
EE14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
RO14.01.2009
SI14.01.2009
SK14.01.2009
BG14.04.2009
SE14.04.2009
GR15.04.2009
IS14.05.2009
PT15.06.2009
HU15.07.2009
Former [2010/51]AT14.01.2009
CZ14.01.2009
DK14.01.2009
EE14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
RO14.01.2009
SI14.01.2009
SK14.01.2009
BG14.04.2009
SE14.04.2009
GR15.04.2009
IS14.05.2009
PT15.06.2009
Former [2010/11]AT14.01.2009
CZ14.01.2009
DK14.01.2009
EE14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
RO14.01.2009
SI14.01.2009
SK14.01.2009
BG14.04.2009
SE14.04.2009
IS14.05.2009
PT15.06.2009
Former [2009/51]AT14.01.2009
CZ14.01.2009
DK14.01.2009
EE14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
RO14.01.2009
SI14.01.2009
SK14.01.2009
SE14.04.2009
IS14.05.2009
PT15.06.2009
Former [2009/46]AT14.01.2009
DK14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
SI14.01.2009
SE14.04.2009
IS14.05.2009
PT15.06.2009
Former [2009/41]AT14.01.2009
FI14.01.2009
NL14.01.2009
PL14.01.2009
SI14.01.2009
SE14.04.2009
IS14.05.2009
PT15.06.2009
Former [2009/36]FI14.01.2009
NL14.01.2009
SI14.01.2009
Former [2009/26]NL14.01.2009
Cited inInternational search[DY]WO9738991  (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-15 * the whole document *;
 [DY]WO9919317  (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-15 * the whole document *;
 [DPX]WO03097649  (PLIVA D D [HR], et al) [DPX] 1-9,11-15 * abstract * * page 2, paragraph 3; example -; claim - *;
 [A]  - BECKER H-D ET AL, "PHOTOCHEMISTRY OF THE ANTHRACENE CHROMOPHORE: NOVEL ISOMERIZATION OF 1-(9-ANTHRYL)-2-BENZOYLETHYLENES", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (1985), vol. 26, no. 12, ISSN 0040-4039, pages 1589 - 1592, XP008045110 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0040-4039(00)98559-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.